Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain
Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03826-6. Epub ahead of print. PMID: 39505759.
Related Posts
We are pleased to announce the appointment of Manuel Celedon, MD, as the inaugural chief of the Division of Addiction Medicine within the Department of[...]
Leuchter RK, Turner WB, Ouyang D. Response to Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2600014. doi: 10.1056/AIp2600014. Epub 2026 Feb[...]
Mann S, Berdahl CT. Letter: Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2501326. doi: 10.1056/AIp2501326. Epub 2026 Feb 26. PMID: 42932501.